176 related articles for article (PubMed ID: 2812955)
1. Clinical significance of circulating immune complex assay in patients with systemic lupus erythematosus.
Phi NC; Chien DK; Chinh DV; Péter G
Acta Med Hung; 1989; 46(2-3):109-20. PubMed ID: 2812955
[TBL] [Abstract][Full Text] [Related]
2. Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: correlation with disease activity in patients with systemic lupus erythematosus.
Kingsmore SF; Thompson JM; Crockard AD; Todd D; McKirgan J; Patterson C; Fay AC; McNeill TA
J Clin Lab Immunol; 1989 Sep; 30(1):45-52. PubMed ID: 2534927
[TBL] [Abstract][Full Text] [Related]
3. Studies on circulating immune complexes. III: Kinetics of the immunoglobulin class of circulating immune complexes in systemic lupus erythematosus.
Miura Y
Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):201-9. PubMed ID: 2739119
[TBL] [Abstract][Full Text] [Related]
4. DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.
Adu D; Dobson J; Williams DG
Clin Exp Immunol; 1981 Mar; 43(3):605-14. PubMed ID: 6974627
[TBL] [Abstract][Full Text] [Related]
5. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
Williams DG; Adu D
Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D-like activity in serum of patients with systemic lupus erythematosus.
Phi NC; Chien DK; Binh VV; Gergely P
J Clin Lab Immunol; 1989 Aug; 29(4):185-8. PubMed ID: 2637363
[TBL] [Abstract][Full Text] [Related]
8. [Clinical relevance of circulating immune complexes in patients with systemic lupus erythematosus and chronic polyarthritis].
Menzel EJ; Smolen JS; Knapp W; Scherak O; Steffen C
Acta Med Austriaca; 1979; 6(5):212-4. PubMed ID: 162334
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes and platelet IgG in various diseases.
Puram V; Giuliani D; Morse BS
Clin Exp Immunol; 1984 Dec; 58(3):672-6. PubMed ID: 6509798
[TBL] [Abstract][Full Text] [Related]
10. [Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus].
Gerasimova EV; Alekberova ZS; Popkova TV; Sobenin IA
Klin Med (Mosk); 2003; 81(9):39-41. PubMed ID: 14598590
[TBL] [Abstract][Full Text] [Related]
11. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
12. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative characteristic of circulating immune complexes in patients with lupus erythematosus and central nervous system disorders].
Ivanova MM; Sykulev IuK; Blizniuk OI; Tumanova IA
Klin Med (Mosk); 1991 Mar; 69(3):58-60. PubMed ID: 2067339
[TBL] [Abstract][Full Text] [Related]
14. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
15. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
[TBL] [Abstract][Full Text] [Related]
16. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
18. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
